Cutting-Edge CABG
Cutting-Edge CABG:
Adding Surgical Ablation Boosts Survival in AF Patients
Coronary artery bypass grafting (CABG) remains the gold standard for patients with severe multivessel coronary disease. But what about the 10–20% of these patients who already have atrial fibrillation (AF) — a rhythm problem that worsens surgical risk and long-term survival?
A landmark analysis published in The Annals of Thoracic Surgery answers that question with data, precision, and a dose of clinical courage: adding surgical ablation to CABG can help these patients live longer — and yet, it’s still not done often enough.
The Study at a Glance
👥
Population
87,000 Medicare patients with preexisting AF who underwent CABG (2008–2019)
⚙️
Exposure
Concomitant surgical ablation during CABG
📈
Key Finding
Only 22% of patients got ablation, even after guidelines in 2017 made it a Class I recommendation .
⏳
Survival Benefit
Risk-adjusted median survival improved by 4.4 months (7.82 vs. 7.46 years; P<0.001) when ablation was performed.
Even More Striking :
patients treated by surgeons who frequently performed ablation gained nearly five months of additional median survival compared to those treated by surgeons who rarely did.
Why This Matters
Surgical ablation restores normal sinus rhythm, potentially reducing tachycardia-induced heart failure and other rhythm-related complications. Dr. Schaffer and colleagues hypothesize that this delayed benefit — emerging over two years after CABG — reflects fewer rhythm-related heart failure events later in life.
Yet despite robust data and strong guideline recommendations, utilization remains low.
In 2019 — two years after the Class I endorsement — only 27% of eligible patients received ablation.
Behind the Numbers:
How They Got It Right
One challenge in analyzing surgical outcomes is bias — healthier patients may be more likely to get the “add-on” procedure. To tackle this, researchers used two complementary methods:
Overlap Propensity Score Weighting
Adjusting for measurable differences in baseline characteristics.
Surgeon-Preference Instrumental Variable Analysis
comparing outcomes among patients treated by surgeons who frequently vs. rarely perform ablation.
This clever design simulates a randomized trial by using natural variations in practice patterns — producing what the team calls a pseudo-randomized distribution. The fact that both methods converged on the same conclusion is scientifically reassuring.
The Surgical Take-Home
Don’t ignore the rhythm problem :
Atrial fibrillation is more than an electrical nuisance — it’s a long-term survival issue.
One operation, two fixes :
Adding ablation during CABG does not require a separate incision or a new admission — it’s efficient care.
Practice variation matters :
Patients treated by surgeons who “believe in ablation” do better, which suggests underutilization may be depriving patients of meaningful benefit.
Moving Forward
This study reinforces what guidelines already recommend: if a patient with AF is undergoing CABG, surgical ablation should be on the table — literally.
As Dr. John Squiers, coauthor of the study, puts it:
“These data underscore the importance of guideline adherence and hopefully will lead to a reevaluation of surgical decision-making for patients with AF.”
Until large-scale randomized trials emerge (and none are on the horizon), this population-based evidence is as strong a signal as clinicians are likely to get — and it points in one clear direction: fix the rhythm while fixing the arteries.
Reference:
Schaffer J, Squiers J, et al. Association of Surgical Ablation During Coronary Artery Bypass Grafting with Survival in Patients with Preexisting Atrial Fibrillation.
Ann Thorac Surg. Published online
June 4, 2025.
https://www.annalsthoracicsurgery.org/article/S0003-4975(25)00339-X/abstract